Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aplicare is a specialized manufacturer of skin antisepsis and infection prevention products for the healthcare industry. The company's product portfolio includes a wide range of topical antiseptic solutions, such as povidone-iodine and chlorhexidine gluconate, delivered via swabs, pads, and bottled solutions. These products are essential for pre-operative skin preparation and general wound care to prevent healthcare-associated infections. Founded in 1983 and headquartered in Meriden, Connecticut, Aplicare has established itself as a trusted provider for hospitals and clinics. In 2012, the company was acquired by The Clorox Company, and subsequently, in 2019, it was sold to Medline Industries, where it now operates as a key brand within their infection prevention division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aplicare.